CoChat

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

Open access

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; 6 of the 61 sources its claims cite were checked for support.

Abstract

Mounting evidence suggests that aberrations in immune-inflammatory pathways contribute to the pathophysiology of major depressive disorder (MDD), and individuals with MDD may have elevated levels of predominantly pro-inflammatory cytokines and C-reactive protein. In addition, previous meta-analyses suggest that antidepressant drug treatment may decrease peripheral levels of interleukin-1 beta (IL-1β) and IL-6. Recently, several new studies examining the effect of antidepressants on these cytokines have been published, and so we performed an updated meta-analysis of studies that measured peripheral levels of cytokines and chemokines during antidepressant treatment in patients with MDD. The PubMed/MEDLINE, EMBASE, and PsycInfo databases were searched from inception through March 9, 2017. Forty-five studies met inclusion criteria (N = 1517). Peripheral levels of IL-6, tumor necrosis factor-alpha (TNF-α), IL-1β, IL-10, IL-2, IL-4, interferon-γ, IL-8, the C-C motif ligand 2 chemokine (CCL-2), CCL-3, IL-1 receptor antagonist, IL-13, IL-17, IL-5, IL-7, and the soluble IL-2 receptor were measured in at least three datasets and thus were meta-analyzed. Antidepressant treatment significantly decreased peripheral levels of IL-6 (Hedges g = −0.454, P <0.001), TNF-α (g = −0.202, P = 0.015), IL-10 (g = −0.566, P = 0.012), and CCL-2 (g = −1.502, P = 0.006). These findings indicate that antidepressants decrease several markers of peripheral inflammation. However, this meta-analysis did not provide evidence that reductions in peripheral inflammation are associated with antidepressant treatment response although few studies provided separate data for treatment responders and non-responders.

Overview

CoChat Summary

TL;DR

This updated systematic review and meta-analysis of 45 studies (N=1517) found that antidepressant drug treatment significantly decreased peripheral levels of IL-6, TNF-α, IL-10, and CCL-2 in patients with major depressive disorder. Reductions in peripheral inflammation were not consistently associated with antidepressant treatment response, and baseline TNF-α did not differ between responders and non-responders.

Key findings

  • Antidepressant treatment significantly reduced peripheral IL-6 (Hedges g = -0.454, P < 0.001), TNF-α (g = -0.202, P = 0.015), IL-10 (g = -0.566, P = 0.012), and CCL-2 (g = -1.502, P = 0.006).
  • IL-1β was not significantly reduced after antidepressant treatment (g = -0.255, P = 0.176; 15 studies; N=331), and 11 additional immune variables meta-analyzed were not significantly altered overall.
  • Composite measures suggested a significant reduction in cytokines/chemokines predominantly secreted by M1 macrophages (g = -0.35, P < 0.001), whereas TH1, TH2, and TReg composites were not significantly altered.
  • Treatment-response analyses were non-significant: TNF-α responders g = -0.346, k=8, P=0.115; TNF-α non-responders g = 0.049, k=7, P=0.590; IL-6 responders g = -0.222, k=4, P=0.480; IL-6 non-responders g = -0.010, k=4, P=0.964. Baseline TNF-α and IL-8 also did not differ between responders and non-responders (TNF-α g = 0.248, k=7, P=0.353; IL-8 g = -0.082, k=3, P=0.595).

Methods

  • Systematic review and within-group meta-analysis following PRISMA; PubMed/MEDLINE, EMBASE, and PsycInfo were searched from inception through March 9, 2017; 45 original studies met inclusion criteria (N=1517). Eligible studies measured peripheral cytokine/chemokine levels in adults (age ≥18) meeting DSM or ICD criteria for MDD, before and after approved antidepressant treatment, with follow-up ≥4 weeks (mean follow-up 7.6 weeks, SD=3.3, range 4–20).
  • Data extraction included means, variance estimates, and sample sizes; mediators with at least 3 datasets were meta-analyzed. Effect sizes were estimated as Hedges’s g with 95% CIs using random-effects models (DerSimonian and Laird); heterogeneity was assessed with Cochran Q and I²; publication bias was assessed with funnel plots, Egger’s test, trim-and-fill, and fail-safe N; subgroup and random-effects meta-regression, sensitivity, and cumulative meta-analyses were also performed.
  • Methodological quality was assessed with 7 parameters; quality scores ranged from 2 to 7 (median: 4).

Limitations

  • The paper states that some potential sources of heterogeneity could not be explored due to lack of data, including BMI for several cytokines/chemokines and smoking data; methodological quality of included studies varied; melancholic versus atypical depression could not be contrasted; and assay standardization/technical challenges may have contributed to heterogeneity.
  • The paper also notes that CCL-2 findings should be interpreted cautiously because the effect did not survive sensitivity analysis, and TNF-α sensitivity analysis showed that exclusion of two individual studies rendered the effect non-significant.
  • Evident from the text: heterogeneity was large for many estimates, including IL-6 (I²=84.7%), TNF-α (I²=80.0%), IL-1β (I²=92.0%), and CCL-2 (I²=96.0%), and few studies provided separate responder/non-responder data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s12035-017-0632-1

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

4 Valid · 1 Not valid · 44 Not checked · 96 Own results and interpretations

71 more claims

Create a free account to see all 145 claims and to verify the 55 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 50
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

13 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, Geneva

Cited by

See all 474

Metadata

Authors
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., Herrmann, N., Raison, C. L., Miller, B. J., Lanctôt, K. L., & Carvalho, A. F.
Affiliations
  • Universidade de Fortaleza (BR)
  • King's College London (GB)
  • Universidade Estadual de Londrina (BR)
  • University of Padua (IT)
  • Deakin University (AU)
  • Universidade Federal do Rio Grande do Sul (BR)
  • Universidade de São Paulo (BR)
  • University of Toronto (CA)
  • University of Wisconsin–Madison (US)
  • Augusta University (US)
Venue
Molecular Neurobiology
Published
2017-06-13
Volume
55
Issue
5
Pages
4195-4206
ISSN
  • 0893-7648 (ISSN-L)
  • 1559-1182
OpenAlex
W2624751168
Cited by
449
References
57
Citations by year
2026: 14 · 2025: 37 · 2024: 44 · 2023: 53 · 2022: 65 · 2021: 86 · 2020: 45 · 2019: 59 · 2018: 39 · 2017: 7
FWCI
2.79
Type
journal article
Language
en
Open access
Locations
  • Molecular Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by-nc-nd)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
Funders
  • National Institute for Health and Care Research (ICA-CL-2017-03-001, NIHR-INF-0685)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
major depressive disorder, antidepressant treatment, cytokines, chemokines, peripheral inflammation, interleukin-6, TNF-α, IL-10, MCP-1, immune-inflammatory pathways, treatment response
MeSH terms
Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Humans, Treatment Outcome, Chemokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1007/s12035-017-0632-1
The paper
Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., Herrmann, N., Raison, C. L., Miller, B. J., Lanctôt, K. L., & Carvalho, A. F. (2017). Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Molecular Neurobiology. https://doi.org/10.1007/s12035-017-0632-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.